Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07637630 · ClinicalTrials.gov registry record · NA
Trial in HPV Prevention for the U.S. Vietnamese Community
A NA study, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT07637630 is a NA study that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 96 participants.
The verdict
NCT07637630, a NA study, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of the HERO study is to leverage the Multiphase Optimization Strategy (MOST) framework to conduct a pilot trial testing four different intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) targeting HPV vaccination among U.S. Vietnamese. PRIMARY AIM To assess the feasibility and acceptability of each of the four digital HERO intervention components in a pilot optimization trial using the MOST framework. Using a highly efficient design, the study team will randomize 96 Vietnamese parents of unvaccinated adolescents to receive 0 to 4 HERO components. The study team will establish the feasibility (reach, retention, adherence) and acceptability (usability, satisfaction, usefulness, cultural relevance) of each component (expert video, self-persuasion, narrative storytelling, and motivational interviewing). SECONDARY AIM To investigate effects of each component on HPV vaccination outcomes and psychosocial mediators. The study team will examine the effects on HPV vaccination (initiation and intention) and psychosocial mediators.
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Expert Video
- BEHAVIORAL Self-persuasion
- BEHAVIORAL Narrative Storytelling
- BEHAVIORAL Constant Component
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07637630
The ClinicalTrials.gov registry entry for NCT07637630 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Motivational Interviewing is the first listed.
NCT07637630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07637630 about?
NCT07637630 is a clinical study titled "Trial in HPV Prevention for the U.S. Vietnamese Community". The purpose of the HERO study is to leverage the Multiphase Optimization Strategy (MOST) framework to conduct a pilot trial testing four different intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) targeting HPV vaccination among U.S. Vietn...
What is the current status of trial NCT07637630?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2026-05-01. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT07637630?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Expert Video (BEHAVIORAL), Self-persuasion (BEHAVIORAL), Narrative Storytelling (BEHAVIORAL), Constant Component (BEHAVIORAL).
Who is sponsoring clinical trial NCT07637630?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.